These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


343 related items for PubMed ID: 15010820

  • 1. Down-regulation of matrix-invasive potential of human liver cancer cells by type I interferon and a histone deacetylase inhibitor sodium butyrate.
    Kaneko F, Saito H, Saito Y, Wakabayashi K, Nakamoto N, Tada S, Suzuki H, Tsunematsu S, Kumagai N, Ishii H.
    Int J Oncol; 2004 Apr; 24(4):837-45. PubMed ID: 15010820
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
    Ramer R, Hinz B.
    J Natl Cancer Inst; 2008 Jan 02; 100(1):59-69. PubMed ID: 18159069
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669
    [Abstract] [Full Text] [Related]

  • 4. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
    Fujiuchi Y, Nagakawa O, Murakami K, Fuse H, Saiki I.
    Oncol Rep; 2003 Dec 19; 10(4):1001-6. PubMed ID: 12792760
    [Abstract] [Full Text] [Related]

  • 5. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C, Chen Z, Li Z, Cen J.
    Leuk Res; 2010 Aug 19; 34(8):1083-90. PubMed ID: 20138666
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells.
    Ramer R, Eichele K, Hinz B.
    Oncogene; 2007 Aug 23; 26(39):5822-7. PubMed ID: 17369856
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ, Park HJ, Chung HJ, Min HY, Park EJ, Hong JY, Lee SK.
    J Nutr Biochem; 2006 May 23; 17(5):356-62. PubMed ID: 16214327
    [Abstract] [Full Text] [Related]

  • 11. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
    Nakamura M, Saito H, Ebinuma H, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Ishii H.
    J Cell Physiol; 2001 Jun 23; 187(3):392-401. PubMed ID: 11319763
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH, Jung YJ, Kim TD, Li G, Park BJ, Kim JY, Lee YC, Kim JM, Park JI, Park HD, No ZS, Lim K, Hwang BD, Kim YS.
    Clin Cancer Res; 2004 Jul 01; 10(13):4517-26. PubMed ID: 15240544
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dibutyryl cyclic AMP-induced enhancement of tissue inhibitor of metalloproteinases-3 expression and its possible relation to the invasive activity of the human hepatoma cell line PLC/PRF/5.
    Okamoto Y, Nakano H.
    Anticancer Res; 1999 Jul 01; 19(6B):5175-80. PubMed ID: 10697530
    [Abstract] [Full Text] [Related]

  • 19. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
    Deryugina EI, Luo GX, Reisfeld RA, Bourdon MA, Strongin A.
    Anticancer Res; 1997 Jul 01; 17(5A):3201-10. PubMed ID: 9413149
    [Abstract] [Full Text] [Related]

  • 20. Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
    Yamashita Y, Ishiguro Y, Sano D, Kimura M, Fujita K, Yoshida T, Horiuchi C, Taguchi T, Matsuda H, Mikami Y, Tsukuda M.
    Auris Nasus Larynx; 2007 Dec 01; 34(4):487-91. PubMed ID: 17337140
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.